Oral Herpes (Cold Sores - HSV-1)

Overview

Plain-Language Overview

Oral Herpes (Cold Sores - HSV-1) is a common viral infection that affects the skin and mucous membranes around the mouth. It is caused by the herpes simplex virus type 1, which leads to painful, fluid-filled blisters commonly known as cold sores. These sores usually appear on or around the lips and can cause discomfort, itching, and sometimes fever or swollen lymph nodes. The virus remains in the body in a dormant state and can reactivate, causing recurrent outbreaks. This condition primarily affects the oral and facial region, impacting daily activities like eating and speaking. It is highly contagious, especially during active outbreaks when the sores are present.

Clinical Definition

Oral Herpes (Cold Sores - HSV-1) is a recurrent infection caused by the herpes simplex virus type 1, a double-stranded DNA virus of the Herpesviridae family. The virus infects epithelial cells of the oral mucosa and skin, causing vesicular lesions that rupture to form painful ulcers. After primary infection, HSV-1 establishes latency in the trigeminal ganglion, with periodic reactivation triggered by factors such as stress, UV light, or immunosuppression. Clinically, it presents as grouped vesicles on an erythematous base, primarily affecting the lips and perioral skin. The infection is significant due to its high prevalence, potential for recurrent painful outbreaks, and risk of transmission. Complications can include herpetic whitlow, keratitis, and, rarely, encephalitis.

Inciting Event

Primary exposure to HSV-1 through saliva or direct contact with lesions initiates infection.
Physical or emotional stress can trigger viral reactivation from latency.
Fever or systemic illness often precedes reactivation episodes.
Ultraviolet light exposure to the lips can precipitate cold sore outbreaks.
Local trauma to the oral mucosa may initiate lesion formation.

Latency Period

Primary infection incubation period ranges from 2 to 12 days before symptom onset.
After primary infection, HSV-1 establishes lifelong latency in sensory ganglia.
Reactivation episodes can occur sporadically and unpredictably over months to years.
Prodromal symptoms typically appear hours to 1 day before lesion development.

Diagnostic Delay

Early lesions may be mistaken for aphthous ulcers or bacterial infections.
Mild or atypical presentations often lead to underrecognition by clinicians.
Lack of awareness of prodromal symptoms delays diagnosis.
Patients may not seek care until painful vesicles or ulcers develop.
Misattribution to other causes of oral lesions delays appropriate antiviral therapy.

Clinical Presentation

Signs & Symptoms

Prodromal burning or tingling sensation at the site before lesion appearance.
Painful grouped vesicles on the lips or oral mucosa that rupture to form shallow ulcers.
Fever and malaise may accompany primary infection or severe outbreaks.
Regional lymphadenopathy often occurs during acute episodes.
Recurrent cold sores triggered by stress, sunlight, or immunosuppression.

History of Present Illness

Initial symptoms include prodromal burning, tingling, or itching at the site of future lesions.
Development of painful grouped vesicles on the lips or perioral skin follows prodrome.
Vesicles rupture to form shallow ulcers with erythematous bases.
Lesions typically heal within 7 to 10 days without scarring.
Recurrent episodes often present with milder symptoms and fewer lesions.

Past Medical History

History of previous HSV-1 infection or cold sores increases likelihood of recurrence.
Immunosuppressive conditions such as HIV/AIDS or cancer chemotherapy worsen disease severity.
Recent febrile illness or upper respiratory infection may precede reactivation.
Use of immunomodulatory medications can increase frequency of outbreaks.
History of eczema or atopic dermatitis may predispose to more severe HSV infections.

Family History

Family members often share history of recurrent oral herpes, indicating common exposure.
No clear genetic inheritance pattern but susceptibility may be influenced by host immune factors.
Rare familial immunodeficiencies affecting T cell function can increase HSV severity.
Positive family history of herpes simplex virus infections suggests increased risk of transmission.
No association with hereditary syndromes but familial clustering is common due to shared environment.

Physical Exam Findings

Grouped vesicles on an erythematous base typically located on the lips or perioral skin.
Crusting and ulceration following vesicle rupture during the healing phase.
Tender regional lymphadenopathy, especially in the submandibular area.
Erythema and edema of the surrounding mucosa or skin during active lesions.
Recurrent lesions often appear at the same site due to viral latency in the trigeminal ganglion.

Diagnostic Workup

Diagnostic Criteria

Diagnosis of oral herpes is primarily clinical, based on the presence of characteristic grouped vesicular lesions on an erythematous base around the oral mucosa or lips. Confirmation can be obtained by polymerase chain reaction (PCR) testing of lesion swabs, which is highly sensitive and specific for detecting HSV-1 DNA. Alternatively, viral culture or direct fluorescent antibody testing can be used. Serologic testing for HSV-1 antibodies is not useful for diagnosing active infection but may indicate prior exposure. The diagnosis is supported by a history of recurrent episodes triggered by known factors.

Pathophysiology

Key Mechanisms

Primary infection and reactivation of herpes simplex virus type 1 (HSV-1) in sensory neurons cause mucocutaneous lesions.
Latency of HSV-1 occurs in the trigeminal ganglion with periodic reactivation triggered by stimuli.
Viral replication in epithelial cells leads to vesicle formation and ulceration on the oral mucosa.
Immune response, including cytotoxic T cells and interferons, limits viral spread but contributes to symptoms.
Direct viral cytopathic effect causes cell lysis and inflammation at the site of infection.

Involvement	Details
Organs	Salivary glands can harbor latent HSV-1 contributing to viral shedding and recurrence
Organs	Trigeminal ganglion serves as the site of HSV-1 latency and reactivation leading to recurrent oral herpes
Tissues	Oral mucosa is the primary site of HSV-1 replication and lesion development in oral herpes
Tissues	Epidermis is involved as HSV-1 infects keratinocytes causing vesicular lesions and ulceration
Cells	Keratinocytes are the primary host cells infected by HSV-1 in oral mucosa, leading to lesion formation
	CD8+ T cells mediate cytotoxic immune response to control HSV-1 infection and limit viral spread
	Langerhans cells act as antigen-presenting cells initiating adaptive immune response against HSV-1
Chemical Mediators	Interferon-alpha is produced in response to HSV-1 infection and inhibits viral replication
	Tumor necrosis factor-alpha (TNF-alpha) promotes inflammation and recruitment of immune cells to infected tissue
	Interleukin-1 (IL-1) contributes to local inflammation and fever during active HSV-1 lesions

Treatments

Pharmacological Treatments

Acyclovir
- Mechanism:
  - Inhibits viral DNA polymerase after phosphorylation by viral thymidine kinase, preventing viral DNA replication
- Side effects:
  - Headache
  - Nausea
  - Renal toxicity
- Clinical role:
  - First-line
Valacyclovir
- Mechanism:
  - Prodrug of acyclovir with improved oral bioavailability that inhibits viral DNA polymerase
- Side effects:
  - Headache
  - Nausea
  - Abdominal pain
- Clinical role:
  - First-line
Famciclovir
- Mechanism:
  - Prodrug converted to penciclovir that inhibits viral DNA polymerase
- Side effects:
  - Headache
  - Nausea
  - Fatigue
- Clinical role:
  - First-line

Non-pharmacological Treatments

Apply cold compresses to reduce pain and inflammation during outbreaks
Maintain good oral hygiene to prevent secondary bacterial infection
Avoid direct contact with lesions to reduce transmission risk

Prevention

Pharmacological Prevention

Daily oral acyclovir or valacyclovir reduces frequency and severity of recurrent outbreaks.
Topical antiviral agents may decrease lesion duration if applied early.
Prophylactic antiviral therapy is recommended for immunocompromised patients to prevent severe disease.

Non-pharmacological Prevention

Avoidance of known triggers such as UV light, stress, and trauma to the lips.
Good hand hygiene to prevent autoinoculation and spread to others.
Use of lip balm with sunscreen to protect against UV-induced reactivation.
Avoiding direct contact with active lesions to reduce transmission risk.

Outcome & Complications

Complications

Herpetic whitlow from autoinoculation to fingers causing painful vesicular lesions.
Herpes simplex encephalitis is a rare but severe CNS complication.
Eczema herpeticum in patients with underlying skin disorders causing widespread HSV infection.
Secondary bacterial superinfection leading to cellulitis or impetigo.

Short-term Sequelae	Long-term Sequelae
Painful oral ulcers impairing eating and hydration. Regional lymphadenopathy resolving with lesion healing. Crusting and scabbing of vesicles during lesion resolution. Transient fever and malaise during primary or severe outbreaks.	Recurrent herpes labialis due to lifelong viral latency in the trigeminal ganglion. Postherpetic neuralgia is uncommon but possible after severe outbreaks. Scarring is rare but may occur after deep ulceration or secondary infection. Psychosocial distress from recurrent visible lesions.

Differential Diagnoses

Oral Herpes (Cold Sores - HSV-1) versus Herpes Zoster (Shingles)

Oral Herpes (Cold Sores - HSV-1)	Herpes Zoster (Shingles)
Recurrent, grouped vesicles on erythematous base typically on the lips or perioral skin	Painful, unilateral vesicular rash following a dermatomal distribution
Caused by herpes simplex virus type 1	Caused by reactivation of varicella-zoster virus
Often presents in children or young adults	More common in older adults or immunocompromised patients

Oral Herpes (Cold Sores - HSV-1) versus Aphthous Ulcers (Canker Sores)

Oral Herpes (Cold Sores - HSV-1)	Aphthous Ulcers (Canker Sores)
Vesicles and ulcers on keratinized mucosa such as the lips and vermilion border	Painful ulcers on non-keratinized oral mucosa (e.g., buccal mucosa, floor of mouth)
Vesicular lesions that rupture to form ulcers	Non-vesicular, recurrent ulcers without preceding vesicles
Caused by viral infection with cytopathic effect	Often associated with immune dysregulation or nutritional deficiencies

Oral Herpes (Cold Sores - HSV-1) versus Impetigo

Oral Herpes (Cold Sores - HSV-1)	Impetigo
Caused by herpes simplex virus type 1	Caused by Staphylococcus aureus or Streptococcus pyogenes
Grouped vesicles on erythematous base that rupture to form shallow ulcers	Honey-colored crusted erosions without vesicles
Responds to antiviral agents such as acyclovir	Responds to topical or systemic antibiotics

Oral Herpes (Cold Sores - HSV-1) versus Contact Dermatitis

Oral Herpes (Cold Sores - HSV-1)	Contact Dermatitis
No specific irritant exposure; viral reactivation triggers	Recent exposure to irritants or allergens near the mouth
Discrete grouped vesicles on an erythematous base	Erythematous, edematous rash with possible vesicles but diffuse and poorly demarcated
Requires antiviral therapy for resolution	Improves with removal of offending agent and topical steroids

Oral Herpes (Cold Sores - HSV-1) versus Hand, Foot, and Mouth Disease

Oral Herpes (Cold Sores - HSV-1)	Hand, Foot, and Mouth Disease
Caused by herpes simplex virus type 1	Caused by coxsackievirus A16 or enterovirus 71
Vesicles localized primarily to the oral and perioral region	Vesicular lesions on hands, feet, and oral mucosa
Can affect all ages but often young adults and children	Primarily affects young children